Tag: Alexion Pharmaceuticals (ALXN)
Gilead and Genmab Agreement. A Quick Look at Moderna
GILEAD & GENMAB To Access Genmab’s (GEN) bispecific antibody technology, Gilead (GILD) signed a new agreement with Genmab. The King of HIV treatment objective is to use its exclusive license from Genmab to produce an HIV bispecific monoclonal antibody therapeutic....
Read More
August 15, 2016
0
Gilead and Genmab Agreement. A Quick Look at Moderna
GILEAD & GENMAB To Access Genmab’s (GEN) bispecific antibody technology, Gilead (GILD) signed a new agreement with Genmab. The King of HIV treatment objective is to use its exclusive license from Genmab to produce an HIV bispecific monoclonal antibody therapeutic....
Read More
August 15, 2016
0
Last Week's Promising News
The Week in Review #13 From the Prohost Portfo lio - 1. Betting on the technology - HALOZYME - As expected, the pulse of fat agreements with HALO is accelerating... ...
Read More
December 11, 2017
0
Gilead and Genmab Agreement. A Quick Look at Moderna
GILEAD & GENMAB To Access Genmab’s (GEN) bispecific antibody technology, Gilead (GILD) signed a new agreement with Genmab. The King of HIV treatment objective is to use its exclusive license from Genmab to produce an HIV bispecific monoclonal antibody therapeutic....
Read More
August 15, 2016
0
Last Week's Promising News
The Week in Review #13 From the Prohost Portfo lio - 1. Betting on the technology - HALOZYME - As expected, the pulse of fat agreements with HALO is accelerating... ...
Read More
December 11, 2017
0
Last Week's Promising News
The Week in Review #13 From the Prohost Portfo lio - 1. Betting on the technology - HALOZYME - As expected, the pulse of fat agreements with HALO is accelerating... ...
Read More
December 11, 2017
0
Alexion Pharmaceuticals to Acquire Portola at $18 Per Share
Alexion to Acquire Portola Alexion ( ALXN ) and Portola ( PTLA ) entered into a definitive merger agreement and Alexion acquired Portola. The Terms of the Merger A subsidiary of Alexion will commence a tender offer to acquire all...
Read More
May 5, 2020
0
Alexion Pharmaceuticals to Acquire Portola at $18 Per Share
Alexion to Acquire Portola Alexion ( ALXN ) and Portola ( PTLA ) entered into a definitive merger agreement and Alexion acquired Portola. The Terms of the Merger A subsidiary of Alexion will commence a tender offer to acquire all...
Read More
May 5, 2020
0
Acquisitions that Make Sense
Acquisitions AstraZeneca Acquires Alexion Pharmaceuticals AstraZeneca ( AZN ) and Alexion Pharmaceuticals ( ALXN ) entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares ( ADSs )...
Read More
December 14, 2020
0
Acquisitions that Make Sense
Acquisitions AstraZeneca Acquires Alexion Pharmaceuticals AstraZeneca ( AZN ) and Alexion Pharmaceuticals ( ALXN ) entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares ( ADSs )...
Read More
December 14, 2020
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)